北美非处方药市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

北美非处方药市场按产品类型、分销渠道(医院药房、零售药房、在线药房、其他分销渠道)和地理位置进行细分。

市场快照

North America OTC Market-1
Study Period: 2018 - 2026
Base Year: 2021
CAGR: 2.7 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

在预测期内,北美非处方药 (OTC) 药物市场预计将以 2.7% 的复合年增长率增长。

非处方药市场是创新驱动的,依赖于针对不同疾病复杂性的创新药物的出现,其强度和疗效各不相同。非处方药的产品创新建立了消费者的信心,并导致对非处方药的需求增加。尽管北美地区的市场份额很高,但与处于全球前沿的其他国家相比,美国的份额较小。这可能是由于美国政府在将药品标示为非处方药时采取了严格的监管措施。但最近,人们对场外交易市场的看法发生了变化。已经确定了潜在的好处,因此,OTC 药物变得更容易获得。

根据 2019 年消费者保健产品协会的数据,据估计,大约 93% 的美国人在寻求专业护理之前更愿意用非处方药治疗他们的小病。对于肌肉骨骼损伤和疾病的治疗,美国的许多患者通常使用非处方外用镇痛剂。抗刺激剂被 FDA 批准用于局部治疗轻微疼痛以及肌肉和关节疼痛,并且通常用于治疗急性肌肉骨骼损伤,例如简单的背痛、关节炎疼痛、劳损、瘀伤和扭伤。因此,由于上述因素,预计市场将在预测期内呈现增长。

报告范围

根据本报告的范围,非处方药被称为非处方药。这些药物可以在没有医生处方的情况下由个人购买,并且在没有医生同意的情况下可以安全食用。北美非处方药市场按产品类型、分销渠道和地理位置进行细分。

By Product Type
Cough, Cold, and Flu Products
Analgesics
Dermatology Products
Gastrointestinal Products
Vitamins, Mineral, and Supplements (VMS)
Weight-loss/Dietary Products
Ophthalmic Products
Sleeping Aids
Other Product Types
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacy
Other Distribution Channels
Geography
North America
United States
Canada
Mexico

Report scope can be customized per your requirements. Click here.

主要市场趋势

预计在北美非处方药市场的预测期内,减肥和膳食产品细分市场将以高复合年增长率增长

据信,减肥和饮食产品部门在预测期内的复合年增长率最高。这主要归因于普通民众对健康意识的提高以及垃圾食品消费的增加,这导致了与生活方式相关的疾病的增加。VMS(维生素、矿物质和补充剂)细分市场被认为拥有最大的市场份额。

VMS 和减肥 OTC 药物对整个市场的贡献最大。这一主要份额的原因是该类别下各种产品的庞大客户群。与其他性质强烈的条件不同,VMS 和减肥条件并不是很麻烦。针对这些情况的非处方药产品比治疗或治愈产品更具有预防性。这就是为什么客户数量比其他适应症的客户数量相对多的原因。

根据消费者保健产品协会 (CHPA) 2019 年报告,估计美国家庭平均每年在 OTC 产品上花费约 442 美元。此外,庞大的客户群会产生高需求,从而产生高收入。由于越来越不健康的人口,VMS产品在发达国家非常受欢迎。因此,由于上述因素,预计该细分市场在未来几年将出现显着增长。

NA OTC key trend 1.png

竞争格局

北美非处方药市场竞争分散,由几个主要参与者组成。就市场份额而言,目前很少有主要参与者主导市场。然而,随着技术进步和产品创新,中小型公司正在通过推出价格更低的新产品来增加其市场占有率。强生、诺华、拜耳、赛诺菲和辉瑞等公司在北美非处方药市场占有重要的市场份额。

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Product Innovations

      2. 4.2.2 Inclination of Pharmaceutical Companies Toward OTC Drugs from RX Drugs

    3. 4.3 Market Restraints

      1. 4.3.1 Probability of Substance Abuse

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product Type

      1. 5.1.1 Cough, Cold, and Flu Products

      2. 5.1.2 Analgesics

      3. 5.1.3 Dermatology Products

      4. 5.1.4 Gastrointestinal Products

      5. 5.1.5 Vitamins, Mineral, and Supplements (VMS)

      6. 5.1.6 Weight-loss/Dietary Products

      7. 5.1.7 Ophthalmic Products

      8. 5.1.8 Sleeping Aids

      9. 5.1.9 Other Product Types

    2. 5.2 By Distribution Channel

      1. 5.2.1 Hospital Pharmacies

      2. 5.2.2 Retail Pharmacies

      3. 5.2.3 Online Pharmacy

      4. 5.2.4 Other Distribution Channels

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Johnson and Johnson

      2. 6.1.2 Novartis AG

      3. 6.1.3 Bayer AG

      4. 6.1.4 Sanofi

      5. 6.1.5 Pfizer Inc

      6. 6.1.6 GlaxoSmithKline Plc

      7. 6.1.7 Perrigo Company Plc

      8. 6.1.8 Takeda Pharmaceutical Company Ltd

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The North America Over the Counter Drugs Market market is studied from 2018 - 2026.

The North America Over the Counter Drugs Market is growing at a CAGR of 2.7% over the next 5 years.

Sanofi, Johnson and Johnson, Novartis AG, Pfizer Inc, Bayer AG are the major companies operating in North America Over the Counter Drugs Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!